Switching from low‐dose thiazide diuretics to sodium–glucose cotransporter 2 inhibitor improves various metabolic parameters without affecting blood pressure in patients with type 2 diabetes and hypertension

AIMS/INTRODUCTION: Sodium–glucose cotransporter 2 (SGLT2) inhibitors function to increase urinary glucose excretion and improve glycemic control in individuals with type 2 diabetes mellitus. SGLT2 inhibitors, as well as diuretics, increase urinary volume, which leads to the reduction of blood pressu...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Diabetes Investig
Autori principali: Kimura, Tomohiko, Sanada, Junpei, Shimoda, Masashi, Hirukawa, Hidenori, Fushimi, Yoshiro, Nishioka, Momoyo, Kinoshita, Tomoe, Okauchi, Seizo, Obata, Atsushi, Kohara, Kenji, Tatsumi, Fuminori, Kamei, Shinji, Nakanishi, Shuhei, Mune, Tomoatsu, Kaku, Kohei, Kaneto, Hideaki
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2017
Soggetti:
Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6031496/
https://ncbi.nlm.nih.gov/pubmed/29110406
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.12774
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi